SCHEMBL10631908

SCHEMBL10631908

C=CCOc1ccccc1NC(C)=O

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.61
LMNA P02545 5/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
POLB P06746 2/20 0.54
LIG1 P18858 1/20 0.54
HSD17B10 Q99714 1/20 0.52
KDM4E B2RXH2 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
RAB9A P51151 2/20 0.51
ALDH1A1 P00352 3/20 0.49
MAPT P10636 1/20 0.49
GAA P10253 1/20 0.49
KMT2A Q03164 3/20 0.48
TSHR P16473 1/20 0.46
NPC1 O15118 1/20 0.46
HPGD P15428 2/20 0.46
MEN1 O00255 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30428722 1.00 BRD4 (0.61) BRD4LMNASMN1; SMN2POLBLIG1
SCHEMBL9570576 0.87 BRD4 (0.65) BRD4LMNASMN1; SMN2POLBHSD17B10
SCHEMBL29953311 0.86 BRD4 (0.63) BRD4LMNASMN1; SMN2POLBHSD17B10
SCHEMBL10745183 0.86 POLB (0.55) BRD4LMNAPOLBLIG1HSD17B10
SCHEMBL2880147 0.85 POLB (0.52) BRD4LMNASMN1; SMN2POLBLIG1
SCHEMBL6210901 0.83 BRD4 (0.60) BRD4LMNASMN1; SMN2POLBHSD17B10
SCHEMBL20037048 0.83 POLB (0.59) BRD4LMNAPOLBLIG1HSD17B10
SCHEMBL6210895 0.83 BRD4 (0.60) BRD4LMNASMN1; SMN2POLBHSD17B10
SCHEMBL11546122 0.82 LMNA (0.75) BRD4LMNASMN1; SMN2POLBHSD17B10
SCHEMBL14019905 0.81 GAA (0.50) BRD4LMNASMN1; SMN2POLBLIG1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11833162-B2 Macrocyclic derivatives, process for preparing same and pharmaceutical compositions containing same LES LABORATOIRES SERVIER (FR) 2023-12-05 US disclosed
EP-3700911-B1 NOVEL MACROCYCLIC DERIVATIVES, PROCESS FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SERVIER LAB (FR) 2023-09-06 EP disclosed
CN-111511750-B Macrocyclic derivatives, process for their preparation and pharmaceutical compositions containing them 法国施维雅药厂 2023-06-13 CN disclosed
EP-3700911-A1 NOVEL MACROCYCLIC DERIVATIVES, PROCESS FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME Les Laboratoires Servier SAS (FR) 2020-09-02 EP disclosed
US-20200253993-A1 NOVEL MACROCYCLIC DERIVATIVES, PROCESS FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME LES LABORATOIRES SERVIER (FR) 2020-08-13 US disclosed
CN-111511750-A Novel macrocyclic derivatives, process for their preparation and pharmaceutical compositions containing them 法国施维雅药厂 2020-08-07 CN disclosed
US-4777237-A HEAT-RESISTANT THERMOSETTING MOLDING MATERIALS RHONE-POULENC SPECIALITIES CHIMIQUES (FR) 1988-10-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11833162-B2 Macrocyclic derivatives, process for preparing same and pharmaceutical compositions containing same C1R, F12, RDX BRD4 2034/4885LMNA 1372/4885SMN1; SMN2 3449/4885
US-20200253993-A1 NOVEL MACROCYCLIC DERIVATIVES, PROCESS FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME C1R, RDX, F12 BRD4 1785/4885LMNA 2127/4885SMN1; SMN2 3624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.